trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'bcsm', 'breast']
#asco22 plenary session fam-trastuzumab deruxtecan-nxki doubles progression-free survival in her2-low metastatic breast cancer - the asco post #bcsm 
Associate Director Community Outreach- Thoracic Oncology-University of Miami @SylvesterCancer , Boricua en la Luna, Tweets are my own. (she/her)